Positive and negative impact of anti-reflux mucosal intervention on gastroesophageal reflux disease
Authors:
- 15 September 2022
- journal article
- research article
- Published by Springer Nature in Surgical Endoscopy
- Vol. 37 (2) , 1060-1069
Abstract
Background Anti-reflux mucosal intervention (ARMI), including anti-reflux mucosectomy (ARMS) and anti-reflux mucosal ablation (ARMA), is a promising endoscopic treatment for gastroesophageal reflux disease (GERD). Few studies reported a detailed analysis of the objective reflux parameters. Methods Patients with chronic PPI-dependent GERD and receiving ARMI were prospectively enrolled. Comprehensive clinical symptom profiles, endoscopy results, and 24-h multichannel intraluminal impedance-pH (MII-pH) monitoring were collected and analyzed before and 3 months after ARMI. Results Twenty-three patients undergoing ARMI (11 ARMS and 12 ARMA) were enrolled. The median (IQR) operative time and post-procedure stays were 50 (46–56) min and 2 (2–2) days without major complications. 73.9% of patients reported subjective global improvement. A significant decrease in the total reflux symptom index score was noted from 12 (5–19) to 8 (4–12) (P = 0.010). The esophageal acid exposure time (AET) significantly decreased from 4.6 (2.8–6.9) to 2.1 (1.1–5.6) (P = 0.013), and the number of acid refluxes and DeMeester score were significantly reduced. Three patients (13%) had increased AET (3.4% to 6.1%, 6.3% to 15.4%, and 3.2% to 5.6%); however, all reported global improvement and two patients could discontinue PPI subjectively. One patient (4.3%) had worsened erosive esophagitis and reflux symptoms. 56.5% of patients stopped PPI. Conclusions ARMI is generally effective and safe in PPI-dependent patients. However, possible negative effects of ARMI exist in some patients; further application of MII-pH is necessitated to evaluate the treatment response after ARMI and avoid the detrimental effect of PPI discontinuation. Graph. Graphical abstractKeywords
Funding Information
- National Taiwan University Hospital (NTUH. 110- 005025, NTUH 111-S0174)
- Ministry of Science and Technology (MOST 108-2628-B-002-019, 109-2628-B-002-036--, 110-2628-B-002-048 -)
This publication has 29 references indexed in Scilit:
- Evaluating the reliability and construct validity of the Eckardt symptom score as a measure of achalasia severityNeurogastroenterology & Motility, 2018
- Normative values and factors affecting water‐perfused esophageal high‐resolution impedance manometry for a Chinese populationNeurogastroenterology & Motility, 2017
- The Chicago Classification of esophageal motility disorders, v3.0Neurogastroenterology & Motility, 2014
- Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study2014
- Validation of the GerdQ questionnaire for the diagnosis of gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 2013
- Prevalence of gastroesophageal reflux disease in a general population in TaiwanJournal of Gastroenterology and Hepatology, 2011
- Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas refluxGut, 2004
- The gastroesophageal flap valve: in vitro and in vivo observationsGastrointestinal Endoscopy, 1996
- The endoscopic assessment of esophagitis: A progress report on observer agreementGastroenterology, 1996
- Predictors of outcome in patients with achalasia treated by pneumatic dilationGastroenterology, 1992